Additional data from the KEYNOTE-859 study of pembrolizumab plus chemotherapy versus placebo plus chemotherapy for advanced HER2-negative gastric or gastroesophageal junction (G/GEJ) cancer
Wyrwicz, L.; Oh, D.; Weber, P.; Bai, Y.; Ryu, M.; Lee, J.; Rivera, F.; Alves, G. Vasconcelos; Garrido, M.; Shiu, K.; Fernandez, M. Gonzalez; Li, J.; Lowery, M.; Cil, T.; Cruz, F.; Qin, S.; Yin, L.; Bordia, S.; Bhagia, P.; Rha, S.哈尔滨医科大学; 同济大学